Line 90: | Line 90: | ||
<li class="lateral"> | <li class="lateral"> | ||
<div class="tab__title" style="line-height: 1.3em;"> | <div class="tab__title" style="line-height: 1.3em;"> | ||
− | <a href="#Part 3. Qualitative analysis | + | <a href="#Part 3. Qualitative analysis " class="lateral inner-link" style="color: #353535;opacity: 1;">  3. Qualitative analysis of aptamer</a> |
</div> | </div> | ||
</li> | </li> | ||
Line 289: | Line 289: | ||
</ol> | </ol> | ||
− | <a class="anchorOffset" id="Part 3. Qualitative analysis | + | <a class="anchorOffset" id="Part 3. Qualitative analysis "></a> |
− | <h3>Part 3. Qualitative analysis | + | <h3>Part 3. Qualitative analysis </h3> |
<h4><b>A.TA cloning</b></h4> | <h4><b>A.TA cloning</b></h4> |
Revision as of 18:41, 20 October 2019
Definition for Abbreviations
Abbreviation of protein:
- NPA: Influenza A virus (A/Michigan/297/2017(H1N1)) nucleocapsid protein (NP) gene, complete cds
- NPB: Nucleoprotein for Influenza B virus (B/Colorado/16/2017) nucleoprotein (NP) gene, complete cds
- HA1: hemagglutinin of Influenza A H1N1 (A/New York/18/2009)
- HA3: hemagglutinin of influenza A H3N2 (A/Perth/16/2009)
Abbreviation of aptamers:
- Apt: aptamer
- Apt- NPA: aptamer which binds to NPA
- Apt- NPB: aptamer which can bind to NP
- Apt-HA1: aptamer which can bind to HA1
- Apt-HA3: aptamer which can bind to HA3
Abbreviation of the SELEX experiment result:
- Ft: fluid collected in the tube after the incubation of SELEX
- W“i” (or w“i”): fluid collected after mixing with washing solution. “i” indicates the number of washing round
- E“i” (or e“i”): fluid collected after mixing with elution buffer. “i” indicates the number of eluting round
- NPA-“i”: the serial number “i” of the Apt-NPA of all the clones we obtained
- NPB-“i”: the serial number “i” of the Apt-NPB of all the clones we obtained
- HA1-“i”: the serial number “i” of the Apt-HA1 of all the clones we obtained
- HA3-“i”: the serial number “i” of the Apt-HA3 of all the clones we obtained
Expression Result
As mentioned in the Experiment section, the production of protein can be roughly divided into three parts: The expression of E.coli, the purification of expressed proteins, and the dialysis and concentration of purified protein.
Part 1. Expression
After expressing our target protein( Protocol), the products were centrifuged to separate the solubles and precipitates. The samples were then checked by SDS page.(figure 1)
Most of the production are found in S and S1, indicating that the expressed proteins are highly soluble. The dark band also indicates that both of them are the main product of E.coli expression.
- 1-a :NPA expression, the framed band is our target NPA protein, approximately 55kDa.
- 1-b :NPB expression, the framed band is our target NPA protein, approximately 65kDa.
Most of the production for both the NPA and NPB are in the soluble solution, indicating that the proteins are soluble. Estimated Protein Molecular weight:
- NPA: Sequence length 1494bp→498 codon,+6 Histidine
- 110Da average/per amino acid→55440Da=55.4kDa
- NPB: Sequence length 1680bp→560 codon+6 Histidine
- 110Da average/per amino acid→ 62260Da=62.3kDa
As seen the figure, many other non-target protein exists in the solution. Hence, purification is taken out in the next step.
Part 2. Purification
We purified our target protein using S1 from the previous step. ( Protocol)The samples were then checked by SDS page and Western Blot. From SDS page, we are able to confirm if we removed other proteins and purified our protein thoroughly.(Figure 2)
From SDS page, we can see that most of the target protein are found in Elution buffer, whereas the other proteins has been washed down during the purification steps, left in L,FT, and W.
- 2-a: An obvious band appears from E1~E8 as framed at 55kDa, the estimated molecular weight of NPA. Barely any other band appear in the elution solutions, indicating that most un-target proteins has been washed down.
- 2-b: An obvious band appears from E1~E5 as framed at 65kDa, the estimated molecular weight of NPB. Barely any other band appear in the elution solutions, indicating that most un-target proteins has been washed down.
Therefore, we confirmed that we purified our target protein thoroughly. Still, we performed Western-Blot to double check whether the product on the estimated sites were our target protein or not.
We added six His-tag to our target protein. Hence, from western blot, we are able to confirm if the proteins we purified are our target proteins by using antibodies who recognize His-tag. The primary antibodies bind to protein with His-tags, secondary antibodies then binds to primary antibodies, and can be recognized by Fluorescent dye. (Figure 3)
From Western-Blot, we can see that the bands were the same sites shown in the SDS-page. This proves that the purified protein in the elution sites contains His-tag.
- 3-a: An obvious band appears from E1~E8 as framed at 55kDa.Indicating that the proteins on the correct site are our target NPA protein.
- 3-b: An obvious band appears from E1~E5 as framed at 65kDa. Indicating that the proteins on the correct site are our target NPB protein.
We have confirmed that the main products in the eluting solution are our target protein.
Part 3. Dialysis &Concentration
The high concentration of imidazole contained in the protein after purification could cause protein self-degeneration or aggregation, effecting the incubation between protein and Carboxyl gel in the next step. Moreover, the concentration was too low to be efficiently used. Thus, we dialyzed and concentrated the purified protein via Dialysis tube.
From Fig.4-a and Fig.4-b,we optimized our sequence to increase the yield of proteins. We can find that the protein increase in concentration. From Fig.4-b and Fig.4-c, We dialyze and concentrate the proteins to remove imidazole and make the concentration enough for performing SELEX.
Part 4. Optimized sequence
Since our protein yields are very low, and couldn’t supply the SELEX use. We use ATGme online tool to optimize the codon. We use this tool to replace the rare codon into the other one that E.coli often expresses and examine unexpected restriction sites. After this program, the protein yield become large.
Aptamer Selection RESULT
Part 1. Evolution of SELEX protocol
Phase 1: SELEX tube
As indicated in the reference papers, a large amount(0.5~1 mg ) of target is required for this method. After three months of protein production, we finally had 0.9 mg of NPA protein to carry out this experiment.
Unfortunately, we did not dialyze our produced protein at that time, resulting in the rapid separation between our gel and protein due to the high concentration of sodium solution. It was going to take another long period of time before having enough protein for a next round SELEX gel preparation. Therefore, we made two alternations to solve this issue:
- Improve our protein yield by adjusting the sequence(see Modeling)
- Seek for other ways to take out SELEX.
However, we still collected useful data regarding to the best environment for aptamer refolding in this experiment.
The amount of the by-products :
When aptamers refold in the ice , there were less by-products than when they refold in room temperature.(figure 5) Thus, we kept the aptamers on ice after degeneration in the following experiments
Phase 2: 96 well plate
In the purpose of reducing the usage of protein for SELEX, we looked over papers and found some papers that perform SELEX in 96- well plate required much less protein.
However, the result for this method did not work well in our experiment(figure 6). We tried two methods as described in the Experiment section, but nothing appeared in the gel electrophoresis after PCR.
Test Strip Experimen
In conclusion, we assumed that insufficient mixing between the aptamer pool and coated protein limited to 96-well plate could lead to separation of all aptamers before Washing.
Phase 3: SELEX in Eppendorf
We concluded that:
- A smaller operation space for SELEX can reduce the usage of protein.
- Sufficient mixure between aptamer pool and target protein is required
- It is more predictable and easy to control/track when protein are incubated with the Carboxyl Gel.
Thus we used Eppendorf as our SELEX tube, and successfully got the following results mentioned in the next part.
Part 2. SELEX result
A. SELEX
- The protocol of SELEX(protocol) involves three solutions: flowthrough, washing, and elution, which respectively include aptamers that didn’t bound to anything, aptamers that bound to the Gel but not the target protein, and aptamers that bound to the target protein.
- Unspecific Test:o ensure that all aptamers we acquired from the elution bound to target protein instead of the Carboxyl Gel, we performed unspecific binding test. The protocol was identical to the normal SELEX, just that no protein were incubated on the Gel.(figure 7)
- In our experiment, Two peeks appear after each round of SELEX, respectively after the washing and eluting step, which indicates the complete separation between the aptamers that didn’t bind to the protein incubated on the gel(washing) or the tightly bound aptamers (elution). (figure 8 ).
- After practicing several rounds(5~6) of SELEX, we chose the eluting peeks as our selected aptamer pools, which were expected to have high specificity towards our target protein, and were then sent to be sequenced.
- The following are the aptamer pools we chose to clone in the next step
We concluded that aptamers that bound to Carboxyl Gel were all washed down during the washing steps.
Part 3. Qualitative analysis
A.TA cloning
- Aptamer pools were cloned into pGEM-T vectors with TA cloning kit, and were amplified and ligated with pGEM-T vector transformed into E.coli DH5α cells. Clones obtained were screened with M13 forward and reverse primers.
- The ones that were at the length of 268np (181+87) indicates that the sequence has been successfully transformed into E.coli (figure 13), and these positive clones were then sent to be sequenced.
B.Sequence analyzation
- Sequence were analyzed via NCBI Basic Local Alignment Search Tool, BLAST.
- Influenza A virus (A/Michigan/297/2017(H1N1)) nucleocapsid protein (NP) gene, complete cdsPDF
- Influenza B virus (B/Colorado/16/2017) nucleoprotein (NP) gene, complete cds PDF
- Influenza A H1N1 (A/New York/18/2009) Hemagglutinin / HA Protein (His Tag) PDF
- Influenza A H3N2 (A/Perth/16/2009) Hemagglutinin / HA Protein (His Tag) PDF
C.ELISA-Characterization of selected aptamers
- The titer value of selected aptamers were determined by ELISA.
- Pre-progress:
Amplify the sequenced DNA by PCR, using primers labeled with Biotin to product aptamers with biotin marker.
- Two types of ELISA were practiced: Non-competitive ELISA and Competitive ELISA.
- Purpose:
To confirm the titer value of aptamer towards target protein. According to the coated protein, we are able to test two important character we intend to understand about the selected aptamers:
- The Affinity→ by coating target protein
- The Specificity→by coating un-target protein.
Non-competitive ELISA:
- Method:
Create a series of protein with different concentration via serial dilution. Coat these protein respectively to 96-well microplate. After blocking, add primary antibodies, the selected aptamers in this experiment. The following steps are the same as described in the Protocol.
- Expectation:
If the affinity was high enough, as the concentration of target protein rises, the bound aptamer would increase too, resulting in the darker color presented.
- Result:
We found out that the result for NPA, NPB and HA3 were more significant. Following are their data:
Competitive ELISA:
- Method:
Coat the protein to 96-well microplate, each well containing the same amount of proteins. After blocking, add primary antibodies, the selected aptamers, at the same time, add protein in different concentration as competition. The following steps are the same as described in the Protocol.
- Expectation:
If the affinity was high enough, as the concentration of competition protein rises, the amount of bound aptamers would decrease, resulting in the lighter color presented.
- Result
We found out that NPA had the most significant result. The followings are its data: NPA(figure15)
Test Strip Experiment:
After testing the titer of our aptamers via ELISA(see result), we have confirmed the characters of our selected aptamers, and Ap-NPA-4, Ap-NPA-5, Ap-HA3-4, Ap-HA3-6 had the best affinity and specificity among them. Hence, we chose Ap-NPA-4 in the first test scrip tryout.
We conjugated Ap-NPA-4 to nanogold (protocol), then tried out two methods as described below. The detailed device design and concept can be seen at Design.
- Direct-Competition:
- Add 8ul of ApNPA-4-nanogold to release pad, and dry it at 37℃
- Add 0.25ul of ApNPA-4/ApNPA-5 on NC paper as test line, and dry it at RT.
- Resemble the whole device as shown in figure 1
- Drop 120ul of sample onto sample pad and see its result
- Sandwich Competition:
- Add 8ul of ApNPA-4-nanogold to release pad, and dry it at 37℃
- Add 0.25ul of NPA(1mg/ml) on NC paper as test line, and dry it at RT.
- Resemble the whole device as shown in figure 1.
- Drop 120ul of sample onto sample pad and see its result
After the first try, the result of Sandwich Competition was more significant, therefore we decided to optimize some condition of it. See Result.
Conclusion:We concluded that NPA-4, NPA-6 had outstanding affinity and specificity towards its target protein. Therefore, we chose them as the sample in the next part.
Part 4. Future work
Other aptamers failed to perform good affinity or specificity. This could be explained by the biotin labeled mechanism: Since only one of the strands of amplified aptamers was labelled with biotin during PCR, only 50% of biotin was able to bind to the right strand that had the function to distinguish the target protein. To solve this problem, we are going to use forward primer labeled with biotin to acquire data in the future.